Sangwook Lim

Guiding curve based on the normal breathing as monitored by thermocouple for regular breathing

Adapting radiation fields to a moving target requires information continuously on the location of internal target by detecting it directly or indirectly. The aim of this study is to make the breathing regular effectively with minimizing stress to the patient. A system for regulating patients breath consists of a respiratory monitoring mask (ReMM), a thermocouple module, a screen, inner earphones, and a personal computer. A ReMM with thermocouple was developed previously to measure the patients respiration. A software was written in LabView 7.0 (National Instruments, TX), which acquires respiration signal and displays its pattern. Two curves are displayed on the screen: One is a curve indicating the patients current breathing pattern; the other is a guiding curve, which is iterated with one period of the patients normal breathing curve. The guiding curves were acquired for each volunteer before they breathed with guidance. Ten volunteers participated in this study to evaluate this system. A cycle of the representative guiding curve was acquired by monitoring each volunteers free breathing with ReMM and was then generated iteratively. The regularity was compared between a free breath curve and a guided breath curve by measuring standard deviations of amplitudes and periods of two groups of breathing. When the breathing was guided, the standard deviation of amplitudes and periods on average were reduced from 0.0029 to 0.00139 (arbitrary units) and from 0.359 s to 0.202 s, respectively. And the correlation coefficients between breathing curves and guiding curves were greater than 0.99 for all volunteers. The regularity was improved statistically when the guiding curve was used.

Cases That Respond to Oncothermia Monotherapy

There is a long history of hyperthermia in oncology, but its wide range acceptance and application are missing even today. A new approach of oncological hyperthermia, oncothermia, looks promising modality of the complementary treatment of advanced malignant cases. Our present paper is targeting this method, trying to answer the question of its feasibility to treat various advanced cases in monotherapy process, as well as its applicability for a long, large number of treatment sessions protocols.

Development of a 3D optical scanner for evaluating patient-specific dose distributions.

PURPOSEnThis paper describes the hardware and software characteristics of a 3D optical scanner (P3DS) developed in-house. The P3DS consists of an LED light source, diffuse screen, step motor, CCD camera, and scanner management software with 3D reconstructed software.nnnMATERIALS AND METHODnWe performed optical simulation, 2D and 3D reconstruction image testing, and pre-clinical testing for the P3DS. We developed the optical scanner with three key characteristics in mind. First, we developed a continuous scanning method to expand possible clinical applications. Second, we manufactured a collimator to improve image quality by reducing scattering from the light source. Third, we developed an optical scanner with changeable camera positioning to enable acquisition of optimal images according to the size of the gel dosimeter.nnnRESULTSnWe confirmed ray-tracing in P3DS with optic simulation and found that 2D projection and 3D reconstructed images were qualitatively similar to the phantom images. For pre-clinical tests, the dose distribution and profile showed good agreement among RTP, optical CT, and external beam radiotherapy film data for the axial and coronal views. The P3DS has shown that it can scan and reconstruct for evaluation of the gel dosimeter within 1 min. We confirmed that the P3DS system is a useful tool for the measurement of 3D dose distributions for 3D radiation therapy QA. Further experiments are needed to investigate quantitative analysis for 3D dose distribution.

Development of a one-stop beam verification system using electronic portal imaging devices for routine quality assurance

In this study, a computer-based system for routine quality assurance (QA) of a linear accelerator (linac) was developed by using the dosimetric properties of an amorphous silicon electronic portal imaging device (EPID). An acrylic template phantom was designed such that it could be placed on the EPID and be aligned with the light field of the collimator. After irradiation, portal images obtained from the EPID were transferred in DICOM format to a computer and analyzed using a program we developed. The symmetry, flatness, field size, and congruence of the light and radiation fields of the photon beams from the linac were verified simultaneously. To validate the QA system, the ion chamber and film (X-Omat V2; Kodak, New York, NY) measurements were compared with the EPID measurements obtained in this study. The EPID measurements agreed with the film measurements. Parameters for beams with energies of 6 MV and 15 MV were obtained daily for 1 month using this system. It was found that our QA tool using EPID could substitute for the film test, which is a time-consuming method for routine QA assessment.

Application of an imaging plate to relative dosimetry of clinical X-ray beams

The authors tested an imaging plate for the dosimetry of photon beams. This test involved measurements using imaging plates and additionally an X-ray film, an ion-chamber, and EGS4 Monte Carlo transport code. As a result, the imaging plate showed potential for portal dosimetry.

Statistical Process Control Analysis for Patient Quality Assurance of Intensity Modulated Radiation Therapy

This study applied statistical process control to set and verify the quality assurances (QA) tolerance standard for our hospital’s characteristics with the criteria standards that are applied to all the treatment sites with this analysis. Gamma test factor of delivery quality assurances (DQA) was based on 3%/3 mm. Head and neck, breast, prostate cases of intensity modulated radiation therapy (IMRT) or volumetric arc radiation therapy (VMAT) were selected for the analysis of the QA treatment sites. The numbers of data used in the analysis were 73 and 68 for head and neck patients. Prostate and breast were 49 and 152 by MapCHECK and ArcCHECK respectively. Cp value of head and neck and prostate QA were above 1.0, Cpml is 1.53 and 1.71 respectively, which is close to the target value of 100%. Cpml value of breast (IMRT) was 1.67, data values are close to the target value of 95%. But value of was 0.90, which means that the data values are widely distributed. Cp and Cpml of breast VMAT QA were respectively 1.07 and 2.10. This suggests that the VMAT QA has better process capability than the IMRT QA. Consequently, we should pay more attention to planning and QA before treatment for breast Radiotherapy.

Evaluation of radiotherapy setup accuracy for head and neck cancer using a 3-D surface imaging system

The purpose of this study was to measure the accuracy of a three-dimensional surface imaging system (3-D SIS) in comparison to a 3-laser system by analyzing the setup errors obtained from a RANDO Phantom and head and neck cancer patients. The 3-D SIS used for the evaluation of the setup errors was a C-RAD Sentinel. In the phantom study, the OBI setup errors without the thermoplastic mask of the 3-laser system vs. the 3-D SIS were measured. Furthermore, the setup errors with the thermoplastic mask of the 3-laser system vs. the 3-D SIS were measured. After comparison of the CBCT, setup correction about 1 mm was performed in a few cases. The probability of the error without the thermoplastic mask exceeding 1 mm in the 3-laser system vs. the 3-D SIS was 75.00% vs. 35.00% on the X-axis, 80.00% vs. 40.00% on the Y-axis, and 80.00% vs. 65.00% on the Z-axis. Moreover, the probability of the error with the thermoplastic mask exceeding 1 mm in the 3-laser system vs. the 3-D SIS was 70.00% vs. 15.00% on the X-axis, 75.00% vs. 25.00% on the Y-axis, and 70.00% vs. 35.00% on the Z-axis. These results showed that the 3-D SIS has a lower probability of setup error than the 3-laser system for the phantom. For the patients, the setup errors of the 3-laser system vs. the 3-D SIS were measured. The probability of the error exceeding more than 1 mm in the 3-laser system vs. the 3-D SIS was shown to be 81.82% vs. 36.36% on the X-axis, 81.82% vs. 45.45% on the Y-axis, and 86.36% vs. 72.73% on the Z-axis. As a result, the 3-D SIS also exhibited a lower probability of setup error for the cancer patients. Therefore, this study confirmed that the 3-D SIS is a promising method for setup verification.

Erratum to: Branch length similarity entropy-based descriptors for shape representation (Journal of the Korean Physical Society, (2017), 71, 10, (727-732), 10.3938/jkps.71.593)

Regrettably, due to a technical error during the production process, there were discrepancies in DOI of the mentioned articles between HTML and PDF files. The DOIs are correct in the PDF files but were incorrect in HTML. The original articles have been corrected. The Publisher apologizes for any inconvenience and confusion caused.

Erratum to: Effect of irradiation on cytokine secretion and nitric oxide production by inflammatory macrophages

This study explored the effects of low-dose and high-dose irradiation on inflammatory macrophage cells, specifically inflammatory cytokine secretion and nitric oxide (NO) production after irradiation. To elucidate the effect of irradiation on active and inactive macrophages, we exposed LPS-treated or untreated murine monocyte/macrophage RAW 264.7 cell lines to low-dose to high-dose radiation (0.01–10 Gy). We analyzed the effects of irradiation on RAW 264.7 cell proliferation by MTT assays and analyzed cytokine secretion and NO production related to inflammation by ELISA assays. Low-to-high doses of radiation did not significantly affect the proliferation of LPS-treated or untreated RAW 264.7 cells. Pro-inflammatory cytokine IL-1s was generally increased in RAW 264.7 cells at 3 days after radiation. Especially, IL-1s was significantly increased in only high dose-irradiation (2 and 10 Gy irradiation) groups in LPS-untreated RAW 264.7 cells but increased in both low and high dose-irradiation groups (0.01–10 Gy) in LPS-treated RAW 264.7 cells at 3 days after irradiation. Whereas, the expression of IL-1s was prolonged in high-dose irradiation group at 5 days after irradiation. The production of anti-inflammatory cytokine IL-10 did not change significantly at 3 days after radiation but was significantly reduced at 5 days after 10 Gy radiation. The effect of irradiation on the secretion of IL-1s and IL-10 was not significantly different between RAW 264.7 cells treated or not treated with LPS. The effect of irradiation on NO secretion by RAW 264.7 cells showed a specific pattern. NO was produced after low-dose irradiation but reduced in a high-dose irradiation group at 3 days after irradiation. However, NO production was not changed after low-dose irradiation and reduced at 5 days after high-dose irradiation. These results showed that irradiation affected the inflammatory system and regulated NO production in both activated and inactivated macrophages through different regulation mechanisms, depending on irradiation dose.

A study on the characteristic of normoxic polymer gel dosimeter according to its composition

In this study, to find the optimal composition of the gel as therapeutic radiation, the amounts of methacrylic acid and gelatin were varied. The polymer gel with various compositions were evaluated for its sensitivity, reproducibility, and accuracy. As the concentration of the gelatine is high, the threshold R2 value increases and the dose response was decreases. As the concentration of the methacrylic acid is high, both the threshold R2 value and the dose response were decrease. As both concentrations of the gelatine and the methacrylic acid is high, the sensitivity to the dose was increases within some range. It was found that the polymer gel composed in this study can be optimized for measuring the therapeutic radiation.